Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesNo improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases - data from the Finnish National Registry for Kidney Diseases
Journal of Rheumatology, 04/16/08
Immonen K et al. - No decline was seen in the number of patients with amyloidosis associated with inflammatory rheumatic diseases accepted for renal replacement therapy (RRT), but it increased over the years. The outcome of patients with amyloidosis and endstage renal disease associated with rheumatic diseases remains poor
Methods- Objective was to assess the incidence and outcome of RRT among pts with amyloidosis associated with inflammatory rheumatic diseases
- 502 pts with amyloidosis entering RRT were identified
- 80% of whom had amyloidosis associated with an underlying rheumatic disease
- They were followed from the time of entering RRT until death or until the end of 2003
- No decline in the no. of pts with amyloidosis entering RRT
- Mean age of pts with RA and juvenile idiopathic arthritis (JIA) increased from 1987 to 2002
- Male sex and a diagnosis of JIA indicated an increased risk of mortality
- The median survival time after entering RRT was 2.11 yrs for RA, 2.37 yrs for ankylosing spondylitis, and 3.05 yrs for JIA
- The 5-y survival rates among pts with the corresponding diagnoses were 18%, 30%, and 27%, respectively
Today in Amyloidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical features and functional significance of the P369S/ R408Q variant in pyrin, the familial Mediterranean fever protein
Annals of Rheumatic Diseases, 12/10/09
MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations
Rheumatology International, 10/16/09
Classification of amyloidosis by laser microdissection and mass spectrometry based proteomic analysis in clinical biopsy specimens
Blood, 10/09/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Open Access Rheumatology: Research and Reviews, 12/10/09
Radiographic Measures to Assess Patients with Rheumatoid Arthritis: Advantages and Limitations
Rheumatic Disease Clinics of North America, 12/10/09
A Biopsychosocial Model to Complement a Biomedical Model: Patient Questionnaire Data and Socioeconomic Status Usually Are More Significant than Laboratory Tests and Imaging Studies in Prognosis of Rheumatoid Arthritis
Rheumatic Disease Clinics of North America, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor